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ABSTRACT
Antimicrobial resistance proﬁles, restriction frag-
ment length polymorphism of the coagulase gene
and repetitive element sequence-based PCR were
used to classify 210 methicillin-resistant Staphylo-
coccus aureus isolates recovered between 1997 and
2005 in two hospitals in Vigo, north-west Spain.
Representative isolates belonging to the epidemic
clones were analysed by spa typing and multilo-
cus sequence typing, and the staphylococcal
chromosomal cassette (SCC)mec type was deter-
mined for all isolates. The New York ⁄ Japan clone
(t002-ST5-II) was detected in Spain for the ﬁrst
time. However, the New York ⁄ Japan and the
Brazilian (t037-ST239-IIIA) clones were replaced
by EMRSA-16 (t018-ST36-II), which at present is
the predominant clone.
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The prevalence of methicillin-resistant Staphylo-
coccus aureus (MRSA) is higher in southern than in
northern Europe [1]. According to a national
multicentre study, the incidence of MRSA in
Spain has increased progressively [2]. During
the 1980s, the Iberian clone spread throughout the
country [3], although subsequent studies have
demonstrated the replacement of this epidemic
clone [4–6]. The aim of the present study was to
identify the epidemic MRSA (EMRSA) clones in
two hospitals in Vigo, north-west Spain, during
the 9-year period 1997–2005. In total, 210 MRSA
isolates were obtained from individual patients:
82 (39%) in internal medicine wards; 71 (33.8%)
in intensive care units; 23 (11%) in trauma units;
and 34 (16.2%) in other wards. The most frequent
sites of isolation of MRSA were wounds (37.5%),
sputum (36.6%) and intravenous catheters (11%).
The frequency of MRSA in Hospital I was 28% in
1998, rising to 43% in 1999, and then decreasing
to 3% in 2005, while in Hospital II the frequency
increased progressively from 16% in 1997 to
22.3% in 2005. An isolate was deﬁned as an
EMRSA strain on the basis of the deﬁnition of
Hoefnagels-Schuermans et al. [7].
Susceptibility testing was performed by the
standard disk-diffusion method according to
CLSI guidelines [8]. Spectinomycin susceptibility
was determined as described previously [9]. The
isolates were conﬁrmed as MRSA by ampliﬁca-
tion of the mecA gene [10]. S. aureus ATCC strains
25923, BAA-40, BAA-41, BAA-43 and BAA-44
were included for quality control purposes. All
isolates were screened for mupirocin resistance by
the disk-diffusion method [11]; MICs were deter-
mined for isolates identiﬁed as resistant, and the
presence of the mupA gene was determined by
PCR [12]. In total, 45 isolates (15 isolates of each
epidemic clone) were tested by the vancomycin
agar screen method to detect heterogeneously
vancomycin-resistant S. aureus or intermediately
vancomycin-resistant S. aureus [13].
Analysis of restriction fragment length poly-
morphism of the coagulase gene (PCR-RFLP coa)
and repetitive element sequence-based PCR (rep-
PCR) were performed as described previously
[14,15]. Patterns differing by one or more bands
were categorised as distinct clonal types. The
staphylococcal chromosome cassette (SCC)mec
structural types were determined by a multiplex
PCR strategy [16]. Randomly selected MRSA
isolates belonging to the epidemic clones were
further studied by spa typing (24 isolates) and
multilocus sequence typing (six isolates) [17,18].
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Themajority (84.8%) ofMRSA isolates belonged
to one of three resistance proﬁles, based on a panel
of 11 antimicrobial agents (Table 1). None of the
45 isolates screened was intermediately vanco-
mycin-resistant S. aureus or heterogeneously
vancomycin-resistant S. aureus. Nine isolates were
resistant to mupirocin by the disk-diffusion
method, and three (1.4%) of these showed high-
levelmupirocin resistance (>256 mg ⁄L). ThemupA
gene was only detected in these three isolates,
of which two were the UK EMRSA-16 strain.
PCR-RFLP coa, rep-PCR and epidemiological
data clustered the majority (86.2%) of the isolates
into three EMRSA clonal types (Table 1). The
remaining isolates (13.8%) were classiﬁed as
sporadic. Overall, 95% of the isolates were hos-
pital-acquired and 5% were associated with other
healthcare facilities; no community MRSA strain
was isolated.
The results of SCCmec typing, spa typing and
multilocus sequence typing are summarised in
Table 1. Fig. 1 illustrates the temporal evolution
of the three EMRSA clones.
Typing is one of the most important steps
involved in understanding and controlling MRSA
infections. Pulsed-ﬁeld gel electrophoresis analy-
sis, although technically demanding, is consid-
ered to be the reference standard typing method
[14]. However, the present study used PCR-RFLP
coa and rep-PCR because of their accessibility for
laboratories with limited resources. Moreover,
these methods have been shown to have a good
correlation with pulsed-ﬁeld gel electrophoresis
analysis [7,14]. These PCR-based methods, in
conjunction with the epidemiological data,
grouped the isolates into three main epidemic
clones. Antimicrobial resistance patterns allowed
a clear distinction among the three epidemic
clones and sporadic isolates, as has been reported
previously [7]. Rapid classiﬁcation of an isolate as
epidemic or sporadic could be very useful in
allowing control measures to be focused on the
most important strains, thereby leading to a
substantial decrease in the incidence of MRSA
and the ﬁnancial and logistical consequences [19].
The limited number of isolates analysed in the
present study by spa typing and multilocus
sequence typing could add some bias to the results.
Nevertheless, the homogeneity in the antimicrobial
resistance patterns and the results of genotyping
support the decision to randomly analyse repre-
sentative strains of the epidemic clones. The Iberian
clone, widespread in Spain before 1996, was not
detected [3,5], and the Brazilian clone predomin-
ated until 2002. The latter clone could have spread
to Vigo from Portugal, where it displaced the
Iberian clone during the 1990s [9]. The subsequent
replacement of the multiresistant Brazilian clone
by the pandemic EMRSA-16 clone suggests that
EMRSA-16 could become the prevalent clone in
Spanish hospitals [4,6]. The EMRSA-16 clone
identiﬁed in the present study was susceptible
to gentamicin but resistant to tobramycin; this
phenotype has become common in French
hospitals [20]. The reason(s) for the emergence
and rapid spread of these strains remains unclear.
To our knowledge, this is the ﬁrst report of the
isolation of the New York ⁄ Japan clone in Spain.
Interestingly, the plasmid pUB110 was absent
from the New York ⁄ Japan isolates, which were
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Fig. 1. Temporal evolution of the three epidemic methicil-
lin-resistant Staphylococcus aureus (MRSA) clones between
1997 and 2005 at the two hospitals included in the study.
Table 1. Phenotypic and genotypic characteristics of the
three major epidemic clones
Genotype:
no. of
isolates
(%)
Resistance
proﬁle:
no. of
isolates
(%)
SCCmec
type
(%)
spaA
type
(no. of
isolates
tested)
Sequence
type (ST)
(no. of
isolates
tested)
Clone
name
A: 76 (36.2) 1: 76 (36.2)a IIIA (36.2) t037 (8) ST239 (2) Brazilian
B: 25 (11.9) 2: 22 (10.5)b II (11.9)d t002 (8) ST5 (2) New York ⁄ Japan
C: 80 (38.1) 3: 80 (38.1)c II (38.1) t018 (8) ST36 (2) EMRSA-16
a(GEN, TOB, CIP, CLI, ERY, SXT, CH)R; (RIF, TET, NIT, SPT)S.
b(CIP, CLI, ERY, SPT)R; (GEN, TOB, SXT, RIF, TET, NIT,CH)S.
c(TOB, CIP, CLI, ERY, SPT)R; (GEN, SXT, TET, NIT, CH)S (variable susceptibility to
RIF).
dThe band corresponding to the pUB110 insertion was not observed.
GEN, gentamicin; TOB, tobramycin; CIP, ciproﬂoxacin; CLIN, clindamycin; ERY,
erythromycin; SXT, trimethoprim–sulphamethoxazole; RIF, rifampicin; TET, tetra-
cycline; NIT, nitrofurantoin; SPT, spectinomycin; CH, chloramphenicol.
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susceptible to gentamicin and tobramycin [16].
A similar observation has been made in Asia [21].
As in other European studies [22], no hetero-
geneously vancomycin-resistant S. aureus or
intermediately vancomycin-resistant S. aureus
isolates were identiﬁed. Nevertheless, it is neces-
sary to continue surveillance for these pheno-
types, as the use of glycopeptides continues to be
high. Despite the increase in mupirocin resist-
ance among MRSA in Spain [11], resistance to
mupirocin remained at a low level (1.4%) in the
present study. However, two MRSA isolates
with high-level mupirocin resistance were iden-
tiﬁed as belonging to the UK EMRSA-16 clone.
As the capacity of this clone to acquire resistance
to mupirocin is unknown, there remains the
possibility of the emergence of MRSA strains
highly resistant to mupirocin in the future.
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